UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
February 5, 2021
Accession Number:
Submission Type:
CIK:
0001335105
Company Name:
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
File Number:
333-252430